Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mohammed Almusallam"'
Autor:
Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, Ali F. Altebainawi, Shmeylan Al Harbi, Abdulrahman Al Shaya, Hisham A. Badreldin, Raed Kensara, Abdullah F. Alharthi, Jahad Alghamdi, Ahad Alawad, Rand Alotaibi, Abdullah Kharbosh, Hessa Al Muqati, Abdulmohsen Alhuwahmel, Mohammed Almusallam, Ghada Albarrak, Ibrahim Al Sulaihim, Bader Alanazi, Bodoor S. Al-Dosari, Ramesh Vishwakarma, Alawi S. Alsaeedi, Ghassan Al Ghamdi, Hadeel Alkofide, Hasan M. Al-Dorzi
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
BackgroundThe cardiovascular complications of Coronavirus Disease 2019 (COVID-19) may be attributed to the hyperinflammatory state leading to increased mortality in patients with COVID-19. HMG-CoA Reductase Inhibitors (statins) are known to have plei
Externí odkaz:
https://doaj.org/article/497e868d0a4c41eabcb9464903f68d69
Autor:
Ohoud Aljuhani, Ghazwa B. Korayem, Ali F. Altebainawi, Abdullah Al Harthi, Hisham A. Badreldin, Muath A. Alsalloum, Khalid Eljaaly, Aisha Alharbi, Rowina Aljehani, Ramesh Vishwakarma, Abeer A. Alenazi, Mai Alalawi, Abdulrahman Alissa, Kholoud Al Aamer, Huda Al Enazi, Mohammed Almusallam, Abdulaziz Alshehri, Rawan Bukhari, Ghaday Alasmari, Maha M. AlQahtani, Sultanah Al Shammari, Hatim O. Alsulaymi, Khalid Al Sulaiman
Publikováno v:
Journal of Intensive Care Medicine. 38:534-543
Background: Tocilizumab (TCZ) has been proposed as potential rescue therapy for severe COVID-19. No previous study has primarily assessed the role of TCZ in preventing severe COVID-19-related multiorgan dysfunction. Hence, this multicenter cohort stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f1a74f6249bfa27802301af9b0d3d52
https://doi.org/10.1177/08850666221150886
https://doi.org/10.1177/08850666221150886
Autor:
Abdulrahman I Alshaya, Khalid Bin Saleh, Mohammed Aldhaeefi, Hisham A Baderldin, Faris Alamoudi, Qusai A Alhamdan, Mohammed Almusallam, Omar Alshaya, Khalid Al Sulaiman, Shaima Alshareef, Shuroug A Alowais, Shmeylan A Al Harbi, Ghassan Alghamdi
Publikováno v:
Infection and drug resistance. 15
Abdulrahman I Alshaya,1â 3 Khalid Bin Saleh,1â 3 Mohammed Aldhaeefi,1â 3 Hisham A Baderldin,1â 3 Farris O Alamody,1 Qusai A Alhamdan,1 Mohammed A Almusallam,1 Omar Alshaya,1â 3 Khalid Al Sulaiman,1â 3 Shaima Alshareef,3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::106b8c2ed19a42be11d3b6205083c9d7
https://pubmed.ncbi.nlm.nih.gov/35498632
https://pubmed.ncbi.nlm.nih.gov/35498632
Autor:
Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, Ali F. Altebainawi, Shmeylan Al Harbi, Abdulrahman Al Shaya, Hisham A. Badreldin, Raed Kensara, Abdullah Al Harthi, Jahad Alghamdi, Ahad Alawad, Rand Alotaibi, Abdullah Kharbosh, Hessa Al Muqati, Abdulmohsen Alhuwahmel, Mohammed Almusallam, Ghada Albarrak, Ibrahim Al Sulaihim, Bader Alanazi, Bodoor S. Al-Dosari, Ramesh Vishwakarma, Alawi S. Alsaeedi, Ghassan Al Ghamdi, Hasan M Al-Dorzi
Background The cardiovascular complications of Severe Coronavirus Disease 2019 (COVID-19) may be attributed to the hyperinflammatory state leading to increased mortality in patients with COVID-19. Statins are known to have pleiotropic and anti-inflam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95aa4aafaf963ac55c2e8fa22f624d44
https://doi.org/10.21203/rs.3.rs-828175/v3
https://doi.org/10.21203/rs.3.rs-828175/v3
Autor:
Abdulrahman Al Shaya, Abdullah Al Harthi, Ohoud Aljuhani, Bodoor S. Al-Dosari, Ramesh Vishwakarma, Abdulmohsen Alhuwahmel, Ghazwa B. Korayem, Jahad Alghamdi, Hisham A. Badreldin, Bader Alanazi, Khalid Al Sulaiman, Ghassan Al Ghamdi, Ibrahim Al Sulaihim, Hasan M. Al-Dorzi, Ali F. Altebainawi, Mohammed Almusallam, Hessa Al Muqati, Rand Alotaibi, Shmeylan Al Harbi, Alawi S. Alsaeedi, Ahad Alawad, Raed Kensara, Abdullah Kharbosh
Purpose The complications of Severe Corona Virus Disease 2019 (COVID-19) are attributed to the overproduction of early response proinflammatory cytokines, causing a systemic hyperinflammatory state. Statins are potentially a potent adjuvant therapy i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc9bf8cfdd74f2185bc0cc97bb860231
https://doi.org/10.21203/rs.3.rs-828175/v2
https://doi.org/10.21203/rs.3.rs-828175/v2